Corey Davis
Stock Analyst at HC Wainwright & Co.
(2.55)
# 2,272
Out of 4,753 analysts
18
Total ratings
66.67%
Success rate
9.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corey Davis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Neutral | $32 → $26 | $0.78 | +3,238.47% | 5 | May 12, 2020 | |
| SCYX SCYNEXIS | Assumes: Buy | $50 | $1.09 | +4,487.16% | 3 | May 7, 2018 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | $560 → $40 | $15.72 | +154.45% | 2 | Apr 10, 2018 | |
| LPCN Lipocine | Initiates: Buy | $170 | $4.54 | +3,644.49% | 1 | Mar 29, 2018 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $20 | $4.48 | +346.43% | 2 | Jan 19, 2018 | |
| PCRX Pacira BioSciences | Initiates: Buy | $50 | $26.59 | +88.04% | 3 | Jan 19, 2018 | |
| CARA Cara Therapeutics | Initiates: Buy | $324 | $4.91 | +6,498.78% | 1 | Jan 19, 2018 | |
| JAZZ Jazz Pharmaceuticals | Initiates: Neutral | $144 | $121.63 | +18.39% | 1 | Aug 25, 2017 |
Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $32 → $26
Current: $0.78
Upside: +3,238.47%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $1.09
Upside: +4,487.16%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560 → $40
Current: $15.72
Upside: +154.45%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $4.54
Upside: +3,644.49%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $4.48
Upside: +346.43%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $26.59
Upside: +88.04%
Cara Therapeutics
Jan 19, 2018
Initiates: Buy
Price Target: $324
Current: $4.91
Upside: +6,498.78%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $121.63
Upside: +18.39%